Glycyrrhiza Polysaccharide Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice

Chunying Huang; Xiaoqi Luo; Lulu Li; Nan Xue; Yuanjie Dang; Hongli Zhang; Jingxuan Liu; Jibing Li; Cuiqin Li; Farong Li

doi:10.1155/2022/1345852

Glycyrrhiza Polysaccharide Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice

Evid Based Complement Alternat Med. 2022 Apr 8:2022:1345852. doi: 10.1155/2022/1345852. eCollection 2022.

Authors

Chunying Huang¹, Xiaoqi Luo¹, Lulu Li¹, Nan Xue¹, Yuanjie Dang¹, Hongli Zhang¹, Jingxuan Liu¹, Jibing Li², Cuiqin Li¹, Farong Li¹

Affiliations

¹ Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry & Ministry of Education & National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xian, Shaanxi Province 710062, China.
² School of Basic Medical Science, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province 611137, China.

Abstract

Background: Licorice is one of the most ubiquitous herbs in traditional Chinese medicine, with notable anti-inflammatory and antiulcerative effects as well as potent digestive disease therapeutic impacts; yet, its active components and mechanisms remain unclear. There is a lot of evidence that Glycyrrhiza polysaccharide (GPS) has antioxidants, improving intestinal flora, anti-inflammatory effects, etc. Hypothesis/Purpose. Here, we investigated the effects of GPS on dextran sulfate sodium (DSS)-induced acute ulcerative colitis (UC) mice and its possible mechanisms.

Methods: GPS (100, 200, and 400 mg/kg) or the positive control drug sulfasalazine (SASP) (200 mg/kg) were orally administered to mice for 8 days. Body weight was recorded daily. Symptoms associated with UC, such as disease activity index (DAI), colon length, spleen weight, and mucosal damage were detected. The possible mechanism of GPS ameliorating enteritis symptoms was explored by detecting intestinal permeability and serum levels of inflammatory factors, and changes in intestinal permeability were expressed by serum concentration of FITC-dextran and D-lactic acid.

Results: The results demonstrated that GPS administration alleviated UC symptoms in colitis mice, including weight loss, DAI index, shorting colon length, and mucosal damage. Mechanistic evaluation revealed that GPS treatment reduced intestinal permeability and serum levels of inflammatory factors: IL-1, IL-6, and TNF-α, while increasing serum levels of the anti-inflammatory factor IL-10, suggesting that GPS's mechanism in UC is related to reducing intestinal permeability and inhibiting the inflammatory response, with intestinal permeability implicated as the initiating mechanism.

Conclusion: This study highlights GPS as a promising therapeutic agent, with high therapeutic efficacy and a good safety profile, for enteritis and beyond.